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IMPORTANCE—Most women having mastectomy for breast cancer treatment do not have breast 
reconstruction.
OBJECTIVE—To examine correlates of reconstruction and determine if there is a significant 
unmet need for reconstruction.
DESIGN—Los Angeles and Detroit SEER registries utilized rapid case ascertainment to identify 
a sample of women diagnosed with breast cancer. Subjects were surveyed a median of 9mos post-
diagnosis initially; those remaining disease-free were surveyed again at 4yrs to determine the 
frequency of immediate and delayed reconstruction, and patient attitudes toward the procedure.
SETTING—Two metropolitan area population-based SEER registries were used to identify 
subjects; Latina/Black women were oversampled to ensure adequate minority representation.
PARTICIPANTS—Women age 20-79 with DCIS and stage 1-3 invasive carcinoma diagnosed 
between 6/05-2/07 were eligible if they could complete a questionnaire in English or Spanish. 
Initial survey was sent to 3252 women. 2290 completed it. 1536 completed the follow-up survey. 
The 485 undergoing initial mastectomy and remaining disease-free at follow-up are this report’s 
subject.
MAIN OUTCOMES/MEASURES—Participants were surveyed a mean of 9mos and again at 
50mos post-diagnosis. Latina and Black women were oversampled.
RESULTS—Response rates in the initial and follow-up surveys were 73% and 68%, respectively 
(overall, 50%). Of 485 patients reporting mastectomy at initial survey and remaining disease-free, 
41.6% had reconstruction—24.8% immediate, 16.8% delayed. Factors significantly associated 
with not receiving reconstruction were Black race, lower education level, older age, major co-
morbidity, and receipt of chemotherapy. Only 13% of women were dissatisfied with 
reconstruction decision making, but dissatisfaction was higher among non-whites in the 
sample(p=.032). The most common patient-reported reasons for not having reconstruction were 
the desire to avoid additional surgery and feeling that it was not important, but 36% expressed fear 
of implants. Reasons for avoiding reconstruction and systems barriers to care varied by race; 
barriers were more common among non-whites. Residual demand for reconstruction at 4yrs was 
low, with only 30/263 non-reconstructed respondents still considering the procedure.
CONCLUSIONS/RELEVANCE—Reconstruction rates largely reflect patient demand; most 
patients are satisfied with reconstruction decision making. Specific approaches are needed to 
address lingering patient-level and systems factors negatively impacting reconstruction use in 
minority women.
Keywords
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Universal coverage for postmastectomy breast reconstruction was mandated following 
enactment of the Women’s Health and Cancer Rights Act in the United States in 1998. In 
spite of guaranteed insurance coverage, the majority of women having a mastectomy for 
breast cancer treatment do not undergo breast reconstruction, with rates of reconstruction 
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ranging from 25%-35% in population-based studies1, 2 of women treated between 
2003-2007. Even among women treated in National Cancer Institute-designated cancer 
centers participating in the National Comprehensive Cancer Network, just over 50% of those 
having mastectomy underwent reconstruction.3 Variations in rates of reconstruction use 
have been associated with age, insurance status, ethnicity, and supply of reconstructive 
surgeons.1-3 This, coupled with evidence of significant between-surgeon variation in 
discussion of reconstruction,4 and patient receipt of mastectomy and breast reconstruction,5 
has suggested that patients’ needs for reconstruction may not be fully addressed. These 
concerns resulted in the passage of a New York State law in 2010 mandating that surgeons 
discuss the availability of breast reconstruction with patients prior to breast cancer treatment, 
provide information about insurance coverage, and refer them to a hospital where 
reconstruction is available if necessary.6 However, little is known about patient perceptions 
regarding reconstruction, and it is unclear whether there is a significant unmet need for 
breast reconstruction. In addition, most studies that have examined reconstruction do not 
include patients who received the surgical procedure later (delayed reconstruction). We have 
previously reported that delayed reconstruction was infrequent in a population-based sample 
of women diagnosed in 2002, and found that only 59% of patients in that study who did not 
undergo reconstruction felt that they were adequately informed about the procedure.7 The 
purpose of this study was to examine the rates of both immediate and delayed breast 
reconstruction, and correlates of their use, in a diverse, population-based sample treated in a 
more recent time period to determine if significant gaps in awareness regarding breast 
reconstruction persist. In addition, we sought to examine patient attitudes toward 
reconstruction and identify whether there is a significant unmet need for reconstruction after 
completion of cancer treatment.
Methods
Study Population and Data Collection
Women in the Los Angeles, California, and Detroit, Michigan metropolitan areas aged 
20-79 years who were diagnosed with ductal carcinoma in situ (DCIS) or invasive breast 
cancer between June 2005-February 2007, and reported to the National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) program registries in the 2 regions, 
were eligible for initial sample selection. Patients were excluded if they had stage IV breast 
cancer, died prior to the initial survey, or could not complete the initial questionnaire in 
English or Spanish. Asian women in Los Angeles also were excluded because of enrollment 
in other studies. Latina (in Los Angeles) and Black (in Los Angeles and Detroit) patients 
were oversampled to ensure sufficient representation of racial/ethnic minorities.
Eligible patients were identified via rapid case ascertainment as they were reported monthly 
to the collaborating SEER registries. Physicians were notified of our intent to contact 
patients, followed by a patient mailing consisting of a letter, survey materials, and a $10 
cash gift to eligible study participants. All materials were sent in English and Spanish to 
those with Spanish surnames. Patients were initially interviewed at an average time of 9 
months after diagnosis (completion window: mean, 9 months; range, 5-14 months). A 
follow-up survey was sent to those who completed the baseline survey approximately 4 
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years after diagnosis (completion window: mean, 50 months; range, 36-65 months). The 
Dillman survey method was used for both surveys to encourage response.10
Figure 1 shows the decay in the sample from initial accrual of patients through to the 
selection of the sample for the analysis in this study: 3252 patients were initially identified 
and sent a baseline survey; 2290 patients (73%) completed that survey; and 1536 patients 
completed the follow-up survey. The analytic sample for this study is the 485 patients who 
reported mastectomy at the initial survey, completed the follow-up survey, and indicated 
that they did not have a recurrence of breast cancer. The study protocol was approved by the 
institutional review boards of the University of Michigan, University of Southern California, 
and Wayne State University.
Measures
A primary outcome of interest was a binary variable that indicated whether or not a patient 
received breast reconstruction at any time since mastectomy, obtained from both surveys. 
The second outcome of interest was patient satisfaction with different aspects of the 
reconstruction decision-making process among all patients, obtained from the follow-up 
survey. Patients were asked to agree/disagree with statements regarding their satisfaction 
with aspects of the breast reconstruction decision-making process:(1) Being satisfied with 
the decision about whether or not to have reconstruction;(2) Not regretting the choice they 
made regarding whether or not to have breast reconstruction;(3) Being satisfied about being 
informed about the issues important to breast reconstruction. The response category format 
was a Likert scale that ranged from 1 (strongly disagree) to 5 (strongly agree). The items 
were re-coded to obtain congruent valence and averaged to make a scale. We dichotomized 
the scale score as low satisfaction (<3) or higher (≥3). In addition, we examined the reasons 
why patients did not have breast reconstruction or delayed reconstruction across 2 
dimensions:1) Patient factors, such as their attitudes toward reconstruction (i.e., worry; too 
much time off work or away from family) or clinical reasons; and 2) Systems factors. 
Patients were asked to what extent each reason contributed to their decision, ranging from 1 
(“not at all”) to 5 (“a lot”) using a Likert scale.
The independent variables considered in this study included patient demographics, patient 
clinical/treatment factors, and site (Detroit versus Los Angeles). Patient demographics 
included age, education, race/ethnicity, partner status, income, insurance types, and smoking 
status. Patient clinical factors included cancer stage, presence of key medical comorbidities 
(chronic obstructive pulmonary disease, heart disease, diabetes, stroke), and breast size. 
Treatment factors included the receipt of chemotherapy, receipt of radiation, and timing of 
reconstruction (delayed or immediate reconstruction after mastectomy). All these variables 
were self-reported except cancer stage. The cancer stage classification used was the 
American Joint Committee on Cancer staging system,11 and was obtained from SEER.
Statistical Analysis
We first conducted an analysis comparing key baseline categorical variables between 
responders (those who completed both the baseline and follow-up surveys) to non-
responders using Chi-squared tests. We then calculated summary statistics on our sample 
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population using percentages for categorical variables, and the mean and standard deviations 
for continuous variables. Logistic regression was used to assess the odds of patients not 
receiving reconstruction after mastectomy. The independent variables for this model 
included age, partner status, education, race/ethnicity, income, insurance types, 
comorbidities, pre-diagnosis bra cup size, cancer stage, receipt of radiation, receipt of 
chemotherapy, receipt of contralateral prophylactic mastectomy (CPM), and SEER site. 
Similarly, we used logistic regression to model the odds of being dissatisfied with the 
decision-making process. The independent variables for this model included the status of 
reconstruction (yes versus no), age, education level, race/ethnicity, marriage/partner status, 
income, insurance type, cancer stage, and SEER site. To achieve parsimony of the 
regression models, we used a backward variable selection method to eliminate the variables 
that did not reach the statistical significance level of 0.10. Finally, we described the 
distribution of responses to a list of reasons why women did not receive reconstruction or 
delayed the procedure. This list was based on the percentages of patients who reported that a 
given issue contributed to their decision to omit or delay reconstruction (“quite a bit” or “a 
lot” versus “somewhat” to “not at all”). We examined the difference in these percentages 
across racial/ethnic groups using Mantel-Haenszel tests.
All the descriptive and regression analyses described above were weighted using survey 
procedures (e.g., PROC SURVEYLOGISTIC for logistic regression) to account for 
differential probabilities of sample selection and non-response, which made our statistical 
inference more representative of the population. An analytic weight was created that 
accounted for the initial sampling design (oversampling of Blacks and Latinas, and 
disproportionate selection across geographic sites) and differential non-response in the 2 
waves of the surveys.12 All analyses used SAS software, Version 9.2 (SAS Institute, Cary, 
NC).
Results
An analysis of sampled patients comparing non-respondents with respondents who 
completed both the initial and the follow-up surveys showed that there were no significant 
differences by age at diagnosis. However, compared with respondents, non-respondents to 
the follow-up survey were more likely to be Black (35.2% versus 26.7%;p<0.001) or Latina 
(17.2% versus 13.3%;p=0.002), more likely to have stage II or III disease (54.9% versus 
37.8%;p<0.001), and more likely to have received mastectomy (37.5% versus 
30.8%;p<0.001).
The characteristics of the patient population are summarized in Table 1. The mean age was 
55.8 years; 42.4% had a high-school–level education or less, and 64.3% had stage I or II 
breast cancer. Postmastectomy radiotherapy was reported by 33.0%, and 11.6% underwent a 
CPM. Overall, 41.6% of the 485 patients treated with mastectomy who remained disease-
free had breast reconstruction: 24.8% (n=146) of the procedures were done at the time of 
mastectomy, and 16.8% (n=76) were delayed. The most common type of reconstruction was 
with implants or tissue expanders, used in 61.9% of those undergoing reconstruction. A 
multivariable regression analysis of factors associated with not undergoing any breast 
reconstruction is shown in Table 2. Black patients, those with a high school or lower 
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education level, those without private insurance, women with any major co-morbid 
condition, older women, and those residing in Los Angeles County were significantly less 
likely to undergo reconstruction than their counterparts. Patients who received 
chemotherapy were also significantly less likely to undergo reconstruction.
Most women reported being satisfied with the decision-making process regarding 
reconstruction: the mean satisfaction score was 3.9 (SE, 0.05) on a 5-point Likert scale. 
About 13.3% of women reported being dissatisfied with the decision-making process (score 
<3). Table 3 shows correlates of dissatisfaction with the reconstruction decision-making 
process. Dissatisfaction with the decision-making process was associated with being Black 
or Latina (p=0.032), but not with lower income levels or level of education.
Reasons for not undergoing reconstruction are summarized in Table 4 for the 263 women 
treated with mastectomy alone. Common reasons among women of all racial/ethnic groups 
were the desire to avoid additional surgery (48.5%) or the feeling that reconstruction was not 
important (33.8%). However, ethnic minority groups were less likely to report the desire to 
avoid additional surgery (70.0% for non-Black, non-Latina patients versus 39.7% and 34.1% 
for Blacks and Latinas, respectively;p<0.001) or that reconstruction was not important 
(42.4% for non-Black, non-Latina patients versus 21.6% and 31.3% for Blacks and Latinas, 
respectively;p=0.043). Fear of implants (36.3%) was another commonly reported reason for 
not undergoing reconstruction. Concerns about interference with the detection of cancer and 
lack of awareness of the availability of reconstruction were cited by 23.9% and 18.1% of the 
sample, respectively. There were significant racial/ethnic gradients for some of the other 
reasons given for not undergoing reconstruction. More Latinas reported concerns about 
interference with cancer detection or complications of the procedure, and not being able to 
take time off from work or family. More Blacks and Latinas reported the systems barrier of 
having no insurance coverage.
Most of the 76 patients who received delayed breast reconstruction reported treatment-
related reasons for delaying reconstruction, including the need to focus on cancer treatment 
(68.7%), or the need to accommodate chemotherapy (50.7%) or radiation (26.3%)(Table 5). 
Fewer than 15% indicated they were unaware of the option of breast reconstruction at the 
time of their breast cancer surgery, or that they had problems with insurance. There was 
little residual demand for breast reconstruction among women who had not undergone the 
procedure by 4 years after diagnosis; only 30 (11.4%) of the 263 respondents who had not 
had reconstruction indicated they were still considering breast reconstruction.
Discussion
Our study suggests that the rate of breast reconstruction after mastectomy has been relatively 
stable over time in 2 large, diverse SEER catchment areas. In our earlier study of women 
identified in the Detroit and Los Angeles SEER registries, and treated between December 
2001 and January 2003, 36% of those undergoing mastectomy had immediate reconstruction 
and an additional 12% underwent delayed reconstruction.7, 13 In our current sample of 
patients diagnosed between July 2005 and February 2007 from the same SEER registries, 
the overall rate of reconstruction was 42% (25% immediate and 17% delayed). These 
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findings are consistent with the 25% to 29% increase in reconstruction seen in statewide 
data from California between 2003 and 2007.2 Albornoz et al14 used the Nationwide 
Inpatient Sample database to examine rates of immediate reconstruction in 2008 and found 
that 37.8% of patients undergoing mastectomy had immediate reconstruction.
Although the optimal rate of breast reconstruction is uncertain, our results suggest that 
patient demand, and clinical and treatment factors largely determined receipt of the 
procedure. A lack of interest in additional surgery at the time of cancer diagnosis was the 
primary reason for not getting reconstruction, both in our current patient sample and in an 
older sample reported by our research team.7, 13 Others have also found that patients’ 
feelings that reconstruction was not important and patients’ desires to avoid additional 
surgery are the major factors responsible for low rates of reconstruction.15 While feeling that 
reconstruction is not important may seem counterintuitive, breast-conserving surgery (BCS) 
with radiation is an alternative way to maintain a breast that is an option for the majority of 
women with early-stage breast cancer,16 involves a smaller surgical procedure with more 
rapid recovery than mastectomy with reconstruction, and results in a sensate breast mound. 
In contrast, mastectomy with reconstruction often requires additional surgical procedures, 
and the reconstructed breast lacks normal sensation, making BCS the preferred choice for 
some women desiring to maintain a breast. Greenberg et al3 have demonstrated a strong 
inverse correlation between institutional rates of BCS and mastectomy with reconstruction 
(r=−0.80,p=0.02), but no correlation between institutional rates of mastectomy alone and 
BCS, or mastectomy alone and mastectomy plus reconstruction.
We found that 17% of mastectomy-treated patients delayed reconstruction. This finding 
from a population study is somewhat higher than what was seen in a series from the MD 
Anderson Cancer Center where 8% of women had delayed reconstruction between 15-27 
months after mastectomy,17 but suggests that most women desiring reconstruction have 
access to immediate breast reconstruction. Patient report of reasons for delaying 
reconstruction clearly showed that coordinating treatment delivery was the major factor in 
the decision to forgo reconstruction in our study population. Another reassuring finding 
from this study is that 4 years after diagnosis, only 30 (11.4%) of the 263 patients who had 
not had reconstruction were still considering it.
Importantly, our results suggest some lingering barriers to breast reconstruction. Black 
patients were less likely than non-Black, non-Latina patients to receive reconstruction. 
Additionally, patients without private insurance plans were less likely to receive 
reconstruction. Patient-reported reasons for not getting reconstruction suggested patient 
knowledge- and attitude-related barriers, and systems issues. One-fifth of women who did 
not get reconstruction reported a lack of knowledge regarding it. Many women continue to 
report fear of implants as one reason for forgoing reconstruction, despite their proven 
safety.18-20 One-fourth of women who did not get reconstruction in our sample reported 
concern about potential interference with cancer detection as a decision factor, in spite of the 
clinical evidence not supporting this contention.20, 21 Furthermore, Latinas were more likely 
than other groups to endorse these beliefs. Results also suggest that there are lingering 
systems-related barriers for some patient subgroups—particularly for Blacks, one-fifth of 
whom reported insurance-related barriers (versus 2% of non-Black, non-Latina patients, and 
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18.6% of Latinas;p=0.001). These findings are consistent with a prior study in this patient 
sample examining racial and ethnic disparities in the use of reconstruction in which minority 
women were found to have lower satisfaction with both information received and decision 
making than Whites.1 Other studies have also observed lower rates of reconstruction among 
Black, Asian,2, 22 and Latina women.15
Some aspects of the study methods merit comment. A strength of the study was its diverse 
population-based sample and rigorous attention to measurement.8, 12 The results are limited 
to women from 2 metropolitan areas and may not reflect access to reconstruction nationally, 
particularly in rural areas where plastic surgeons may be less available. The study was 
retrospective in design, and patient recall of their clinician encounters may have varied over 
time. Finally, there was substantial decay in the longitudinal sample, which may have 
introduced selection bias.
In summary, we found that women are largely satisfied with breast-reconstruction decision 
making and that stable rates of receipt of the procedure largely reflect patient demand. A 
minority of women delayed reconstruction within 4 years of cancer diagnosis, and delay was 
largely explained by relevant clinical and treatment-related factors. These findings suggest 
that legislative mandates to change the approach to patient education, such as a recent New 
York State law passed in 2010, are likely to be less effective than more ground-level 
practice initiatives such as patient decision tools or encouraging input from plastic surgeons 
at time of treatment decision making.5, 7 Our study does suggest that there is room for 
improved education regarding the safety of breast implants and impact of reconstruction on 
follow-up surveillance, information which could be readily addressed through decision 
tools. Finally, there is a need to develop specific approaches to address patient-level land 
systems factors that negatively impacted the use of reconstruction among minority women.
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Figure 1. CONSORT Flow Diagram of Patients and Decay in the Sample
SEER, National Cancer Institute Surveillance, Epidemiology, and End Results.
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Table 1
Demographic and Clinical Characteristics of Breast Cancer Cases with Mastectomy (n=485)
Variables Number Weighted %‡
Reconstruction timing
 No reconstruction 263 58.4
 Immediate reconstruction 146 24.8
 Delayed reconstruction 76 16.8
Type of reconstruction
 Autologous tissue 68 38.1
 Implant 141 61.9
Age, mean (SE), y 485 55.8(0.7)
BMI, mean (SE) 459 28.7(0.4)
Breast size
 A or B 168 35.7
 C 165 37.9
 D and above 131 26.5
Race
 Non-Black, Non-Latina 233 40.9
 Black 104 15.3
 Latina 148 43.7
Education level
 High school or less 174 42.2
 Some college or more 306 57.8
Insurance type
 None 39 10.0
 Private 283 57.7
 Medicaid 47 12.1
 Medicare 99 20.2
Income
 < $20,000 84 17.6
 $20,000 to $69,999 167 34.5
 ≥ $70,000 146 26.8
 Unknown 88 21.1
Married or partnered
 Yes 288 59.8
 No 195 40.2
One or more chronic condition(s)†
 Yes 98 19.6
 No 387 80.4
Smoking
 Yes 73 13.6
 No 409 86.4
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Variables Number Weighted %‡
AJCC stage
 0 99 14.2
 I 133 24.7
 II 164 39.6
 III 87 21.5
Postmastectomy radiation therapy receipt
 Yes 144 33.0
 No 322 67.0
Chemotherapy receipt
 Yes 278 65.0
 No 198 35.0
Contralateral prophylactic mastectomy
 Yes 56 11.6
 No 429 88.4
†
chronic obstructive pulmonary disease, heart disease, diabetes, stroke
‡
Percentages are weighted to account for the sample design and non-response.
Abbreviations: SE, standard error; BMI, body mass index; AJCC, American Joint Committee on Cancer.
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Table 2
Adjusted Odds Ratios for Non-receipt of Reconstruction (n=471a)
Variables OR 95% CI p-value
Chemotherapy
 No 1.00
 Yes 1.82 0.99 to 3.31 0.050
Major comorbidities
 No 1.00
 Yes 2.27 1.01 to 5.11 0.048
Age, 10 years 2.53 1.77 to 3.61 <.0001
Education level
 Some college or higher 1.00
 High school or less 4.49 2.31 to 8.72 <.0001
Insurance 0.044
 Private 1.00
 Medicaid 2.72 1.11 to 6.64
 Medicare 2.43 0.87 to 6.79
 None 2.81 1.06 to 7.50
Race 0.004
 Non-Black/Non-Latina 1.00
 Black 2.16 1.11 to 4.20
 Latina 0.62 0.28 to 1.37
Site
 Detroit 1.00
 Los Angeles 1.90 1.03 to 3.50 0.041
a
30 patients were not included because of missing values for dependent or independent variables.
Abbreviations: OR, odds ratio; CI, confidence interval.
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Table 3
Adjusted Odds Ratios for Dissatisfaction with the Reconstruction Decision-Making Process (n=470a)
Variables OR 95% CI p-value
Income 0.148
 >$70,000 1.00
 <$20,000 2.00 0.75 to 5.34
 $20,000 to $69,999 1.29 0.53 to 3.11
 Unknown 0.58 0.16 to 2.16
Education level
 Some college or higher 1.00
 High school or less 1.69 0.76 to 3.73 0.195
Race 0.032
 Non-Black/Non-Latina 1.00
 Black 2.87 1.27 to 6.51
 Latina 2.03 0.89 to 4.67
a
15 patients were not included because of missing values for dependent or independent variables.
Abbreviations: OR, odds ratio; CI, confidence interval
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Table 4




%‡ % % % %
Patient factors
 Did not want additional surgery 48.5 70.0 39.7 34.1 <0.001
 Was not important 33.8 42.4 21.6 31.3 0.043
 Fear of implants 36.3 34.4 38.8 40.7 0.731
 Concerned about interference with detection of
 recurrence 23.9 16.1 18.6 32.5 0.066
 Concerned about possible complications 33.6 27.9 20.4 43.8 0.017
 Could not take much time off work or family 16.1 8.9 9.5 24.7 0.022
Systems factors
 Did not know was an option 18.1 12.7 27.7 18.6 0.514
 Trouble finding surgeon 5.6 4.2 10.6 4.7 0.514
 No insurance coverage 11.8 2.2 23.7 18.6 0.001
 Surgeon did not take insurance 7.8 2.8 16.8 8.5 0.085
†
P-value tests for differences in item response across race/ethnic groups.
‡
Percent that indicated the factor contributed “quite a bit” or “a lot” to the decision to not have breast reconstruction. Percentages are weighted to 
account for the sample design and non-response.
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Table 5
Reasons Given by Patients for Delay in Breast Reconstruction (n=76)
%†
Patient factors: clinical
 Needed radiation therapy 26.3
 Needed chemotherapy 50.7
 Focused on treating the cancer 68.7
Patient factors: attitudes
 Not sure wanted reconstruction 10.1
 Too much time off work or family 6.7
Systems factors
 Did not know of the reconstruction option 14.3
 Trouble finding surgeon to perform reconstruction 0.0
 Problems with initial breast surgery 8.1
 No insurance coverage 10.3
†
Percent that indicated the factor contributed “quite a bit” or “a lot” to the decision to delay breast reconstruction. Percentages are weighted to 
account for the sample design and non-response.
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